These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 35749312)

  • 41. Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services.
    Landes SD; Turk MA; Damiani MR; Proctor P; Baier S
    JAMA Netw Open; 2021 Jun; 4(6):e2112862. PubMed ID: 34100935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hospitalizations and mortality in the United States for adults with Down syndrome and congenital heart disease.
    Baraona F; Gurvitz M; Landzberg MJ; Opotowsky AR
    Am J Cardiol; 2013 Apr; 111(7):1046-51. PubMed ID: 23332593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 and risk of subsequent life-threatening secondary infections: a matched cohort study in UK Biobank.
    Hou C; Hu Y; Yang H; Chen W; Zeng Y; Ying Z; Hu Y; Sun Y; Qu Y; Gottfreðsson M; Valdimarsdóttir UA; Song H
    BMC Med; 2021 Nov; 19(1):301. PubMed ID: 34781951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran.
    Hosseinzadeh A; Sahab-Negah S; Nili S; Aliyari R; Goli S; Fereidouni M; Alami A; Shati M; Ahmadnezhad E; Mehravaran S; Fateh M; Khajeha H; Emamian Z; Behmanesh E; Mahdavi S; Enayatrad M; Mangolian Shahrbabaki P; Ansari-Moghaddam A; Heidarzadeh A; Shahraki-Sanavi F; Hashemi Shahri SM; Dehghan M; Amini Moridani M; Sheibani H; Abbaszadeh M; Jafari R; Valikhani M; Binesh E; Vahedi H; Chaman R; Khodashahi R; Amini M; Jabbari Azad F; Rezaeitalab F; Amel Jamehdar S; Eshraghi A; Sharifi H; Hashemi Bajgani SM; Mahdavi A; Jafarzadeh A; Farokhnia M; Ebrahimi S; Pardakhti A; Ghaderi E; Soltani H; Jadidoleslami S; Arianejad A; Gavili H; Moradveisi B; Motamedi D; Zare H; Kazemi T; Emamian MH
    Bull World Health Organ; 2022 Aug; 100(8):474-483. PubMed ID: 35923277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risks of late mortality and morbidity among survivors of childhood acute leukemia with Down syndrome: A population-based cohort study.
    Gupta S; Sutradhar R; Pequeno P; Hitzler JK; Liu N; Nathan PC
    Cancer; 2022 Mar; 128(6):1294-1301. PubMed ID: 34847248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey.
    Pinku H; Hüls A; Feany PT; Baumer N; Dierssen M; Bargagna S; Costa AC; Chicoine BA; Rebillat AS; Sgandurra G; Valentini D; Rohrer RT; Levin J; Lakhanpaul M; Carfì A; Sherman SL; Strydom A; Ghosh S;
    J Glob Health; 2022 Aug; 12():05035. PubMed ID: 35932238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey.
    Emes D; Hüls A; Baumer N; Dierssen M; Puri S; Russell L; Sherman SL; Strydom A; Bargagna S; Brandão AC; Costa ACS; Feany PT; Chicoine BA; Ghosh S; Rebillat AS; Sgandurra G; Valentini D; Rohrer TR; Levin J; Lakhanpaul M; On Behalf Of The Trisomy Research Society Covid-Initiative Study Group
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Healthcare and Behavior Changes for Adults With Down Syndrome 1-Year Into COVID-19.
    Rubenstein E; Kyprianou N; Kumar PS; Kriova AM; Sokoloff A; Hillerstrom H; Hendrix J
    Am J Intellect Dev Disabil; 2023 Jul; 128(4):273-281. PubMed ID: 37470258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey.
    Hüls A; Costa ACS; Dierssen M; Baksh RA; Bargagna S; Baumer NT; Brandão AC; Carfi A; Carmona-Iragui M; Chicoine BA; Ghosh S; Lakhanpaul M; Manso C; Mayer MA; Ortega MDC; de Asua DR; Rebillat AS; Russell LA; Sgandurra G; Valentini D; Sherman SL; Strydom A;
    EClinicalMedicine; 2021 Mar; 33():100769. PubMed ID: 33644721
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of Infectious Diseases Among 6078 Individuals With Down Syndrome in the United States.
    Fitzpatrick V; Rivelli A; Chaudhari S; Chicoine L; Jia G; Rzhetsky A; Chicoine B
    J Patient Cent Res Rev; 2022; 9(1):64-69. PubMed ID: 35111884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review.
    Silva MVGD; Pereira LRG; Avó LRDS; Germano CMR; Melo DG
    Sao Paulo Med J; 2023; 142(2):e2023015. PubMed ID: 37610949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease.
    Malle L; Gao C; Hur C; Truong HQ; Bouvier NM; Percha B; Kong XF; Bogunovic D
    Genet Med; 2021 Mar; 23(3):576-580. PubMed ID: 33060835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific Susceptibility to COVID-19 in Adults with Down Syndrome.
    Illouz T; Biragyn A; Frenkel-Morgenstern M; Weissberg O; Gorohovski A; Merzon E; Green I; Iulita F; Flores-Aguilar L; Dierssen M; De Toma I; Lifshitz H; Antonarakis SE; Yu E; Herault Y; Potier MC; Botté A; Roper R; Sredni B; Sarid R; London J; Mobley W; Strydom A; Okun E
    Neuromolecular Med; 2021 Dec; 23(4):561-571. PubMed ID: 33660221
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics and comorbidities of COVID-19 in unvaccinated patients with Down syndrome: first year report in Brazil.
    Boschiero MN; Palamim CVC; Ortega MM; Marson FAL
    Hum Genet; 2022 Dec; 141(12):1887-1904. PubMed ID: 35763088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Severe Coronavirus Disease 2019 Disease in Individuals With Down Syndrome: A Matched Cohort Study From a Large, Integrated Health Care System.
    Ku JH; Levin MJ; Luo Y; Florea A; Lin IC; Tian Y; Tseng HF
    J Infect Dis; 2022 Sep; 226(5):757-765. PubMed ID: 35749312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 in patients with Down syndrome.
    Emami A; Javanmardi F; Akbari A; Asadi-Pooya AA
    Neurol Sci; 2021 May; 42(5):1649-1652. PubMed ID: 33523318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
    Foxworthy B; Dai C; Davis EC; Xavier AC; Brackett J; Dickens D; Kahn A; Martinez I; Sharma A; Schwalm C; Foley J; Wilkes J; ; Bhatia S; Levine JM; Johnston EE; Wolfson JA
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31082. PubMed ID: 38804869
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.